ETNPPL
Ethanolamine-phosphate phospho-lyase
Also known as: AGXT2L1, AT2L1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBG4
- Gene
- ETNPPL
- Ensembl
- ENSG00000164089
- Chromosome
- 4
- Canonical length
- 499 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Enables ethanolamine-phosphate phospho-lyase activity. Predicted to act upstream of or within several processes, including cellular response to glucocorticoid stimulus; ceramide phosphoethanolamine catabolic process; and phospholipid transfer to membrane. Predicted to be located in mitochondrial matrix. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
499 residues, UniProt reviewed canonical sequence.
>Q8TBG4|ETNPPL
1 MCELYSKRDT LGLRKKHIGP SCKVFFASDP IKIVRAQRQY MFDENGEQYL DCINNVAHVG
61 HCHPGVVKAA LKQMELLNTN SRFLHDNIVE YAKRLSATLP EKLSVCYFTN SGSEANDLAL
121 RLARQFRGHQ DVITLDHAYH GHLSSLIEIS PYKFQKGKDV KKEFVHVAPT PDTYRGKYRE
181 DHADSASAYA DEVKKIIEDA HNSGRKIAAF IAESMQSCGG QIIPPAGYFQ KVAEYVHGAG
241 GVFIADEVQV GFGRVGKHFW SFQMYGEDFV PDIVTMGKPM GNGHPVACVV TTKEIAEAFS
301 SSGMEYFNTY GGNPVSCAVG LAVLDIIENE DLQGNAKRVG NYLTELLKKQ KAKHTLIGDI
361 RGIGLFIGID LVKDHLKRTP ATAEAQHIIY KMKEKRVLLS ADGPHRNVLK IKPPMCFTEE
421 DAKFMVDQLD RILTVLEEAM GTKTESVTSE NTPCKTKMLK EAHIELLRDS TTDSKENPSR
481 KRNGMCTDTH SLLSKRLKTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ETNPPL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 265 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 265 nTPM
- amygdala: 263 nTPM
- liver: 179 nTPM
- cerebral cortex: 177 nTPM
- midbrain: 143 nTPM
- hippocampal formation: 112 nTPM
Single-cell type
- astrocytes: 514 nCPM
- bergmann glia: 176 nCPM
- parietal cells: 118 nCPM
- salivary acinar cells: 40 nCPM
- hepatocytes: 34 nCPM
- salivary myoepithelial cells: 18 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 239 nTPM
- amygdala: 237 nTPM
- hypothalamus: 223 nTPM
- cerebral cortex: 191 nTPM
- hippocampal formation: 172 nTPM
- midbrain: 165 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.73
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to glucocorticoid stimulus
- lipid homeostasis
- phospholipid transfer to membrane
- response to food
- ceramide phosphoethanolamine catabolic process
Molecular functions
- pyridoxal phosphate binding
- transaminase activity
- ethanolamine-phosphate phospho-lyase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ETNPPL as an antibody target. Whether an autoantibody or antibody against ETNPPL could matter depends on whether native ETNPPL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ETNPPL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ETNPPL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...